The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Immuno-Oncology Treatment Market Research Report 2025

Global Immuno-Oncology Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1925134

No of Pages : 85

Ask Your Query
Synopsis
The global Immuno-Oncology Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Immuno-Oncology Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immuno-Oncology Treatment.
Report Scope
The Immuno-Oncology Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immuno-Oncology Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immuno-Oncology Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda
Segment by Type
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Segment by Application
Hospitals
Ambulatory Surgical Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immuno-Oncology Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-Oncology Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Monoclonal Antibodies
1.2.4 Cytokine-Based Immunotherapy
1.2.5 Cancer Vaccines
1.2.6 CAR-T Cell Therapy
1.3 Market by Application
1.3.1 Global Immuno-Oncology Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immuno-Oncology Treatment Market Perspective (2019-2030)
2.2 Immuno-Oncology Treatment Growth Trends by Region
2.2.1 Global Immuno-Oncology Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Immuno-Oncology Treatment Historic Market Size by Region (2019-2024)
2.2.3 Immuno-Oncology Treatment Forecasted Market Size by Region (2025-2030)
2.3 Immuno-Oncology Treatment Market Dynamics
2.3.1 Immuno-Oncology Treatment Industry Trends
2.3.2 Immuno-Oncology Treatment Market Drivers
2.3.3 Immuno-Oncology Treatment Market Challenges
2.3.4 Immuno-Oncology Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno-Oncology Treatment Players by Revenue
3.1.1 Global Top Immuno-Oncology Treatment Players by Revenue (2019-2024)
3.1.2 Global Immuno-Oncology Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Immuno-Oncology Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immuno-Oncology Treatment Revenue
3.4 Global Immuno-Oncology Treatment Market Concentration Ratio
3.4.1 Global Immuno-Oncology Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Treatment Revenue in 2023
3.5 Immuno-Oncology Treatment Key Players Head office and Area Served
3.6 Key Players Immuno-Oncology Treatment Product Solution and Service
3.7 Date of Enter into Immuno-Oncology Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno-Oncology Treatment Breakdown Data by Type
4.1 Global Immuno-Oncology Treatment Historic Market Size by Type (2019-2024)
4.2 Global Immuno-Oncology Treatment Forecasted Market Size by Type (2025-2030)
5 Immuno-Oncology Treatment Breakdown Data by Application
5.1 Global Immuno-Oncology Treatment Historic Market Size by Application (2019-2024)
5.2 Global Immuno-Oncology Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Immuno-Oncology Treatment Market Size (2019-2030)
6.2 North America Immuno-Oncology Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Immuno-Oncology Treatment Market Size by Country (2019-2024)
6.4 North America Immuno-Oncology Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immuno-Oncology Treatment Market Size (2019-2030)
7.2 Europe Immuno-Oncology Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Immuno-Oncology Treatment Market Size by Country (2019-2024)
7.4 Europe Immuno-Oncology Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immuno-Oncology Treatment Market Size (2019-2030)
8.2 Asia-Pacific Immuno-Oncology Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Immuno-Oncology Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Immuno-Oncology Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immuno-Oncology Treatment Market Size (2019-2030)
9.2 Latin America Immuno-Oncology Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Immuno-Oncology Treatment Market Size by Country (2019-2024)
9.4 Latin America Immuno-Oncology Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immuno-Oncology Treatment Market Size (2019-2030)
10.2 Middle East & Africa Immuno-Oncology Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Immuno-Oncology Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Immuno-Oncology Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Immuno-Oncology Treatment Introduction
11.1.4 Amgen Revenue in Immuno-Oncology Treatment Business (2019-2024)
11.1.5 Amgen Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Immuno-Oncology Treatment Introduction
11.2.4 AstraZeneca Revenue in Immuno-Oncology Treatment Business (2019-2024)
11.2.5 AstraZeneca Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Treatment Business (2019-2024)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Eli-Lilly
11.4.1 Eli-Lilly Company Detail
11.4.2 Eli-Lilly Business Overview
11.4.3 Eli-Lilly Immuno-Oncology Treatment Introduction
11.4.4 Eli-Lilly Revenue in Immuno-Oncology Treatment Business (2019-2024)
11.4.5 Eli-Lilly Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Immuno-Oncology Treatment Introduction
11.5.4 Roche Revenue in Immuno-Oncology Treatment Business (2019-2024)
11.5.5 Roche Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Detail
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Immuno-Oncology Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Immuno-Oncology Treatment Business (2019-2024)
11.6.5 GlaxoSmithKline Recent Development
11.7 Janssen Biotech
11.7.1 Janssen Biotech Company Detail
11.7.2 Janssen Biotech Business Overview
11.7.3 Janssen Biotech Immuno-Oncology Treatment Introduction
11.7.4 Janssen Biotech Revenue in Immuno-Oncology Treatment Business (2019-2024)
11.7.5 Janssen Biotech Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Immuno-Oncology Treatment Introduction
11.8.4 Merck Revenue in Immuno-Oncology Treatment Business (2019-2024)
11.8.5 Merck Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Immuno-Oncology Treatment Introduction
11.9.4 Novartis Revenue in Immuno-Oncology Treatment Business (2019-2024)
11.9.5 Novartis Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Immuno-Oncology Treatment Introduction
11.10.4 Pfizer Revenue in Immuno-Oncology Treatment Business (2019-2024)
11.10.5 Pfizer Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Detail
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Immuno-Oncology Treatment Introduction
11.11.4 Sanofi Revenue in Immuno-Oncology Treatment Business (2019-2024)
11.11.5 Sanofi Recent Development
11.12 Spectrum Pharmaceuticals
11.12.1 Spectrum Pharmaceuticals Company Detail
11.12.2 Spectrum Pharmaceuticals Business Overview
11.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Introduction
11.12.4 Spectrum Pharmaceuticals Revenue in Immuno-Oncology Treatment Business (2019-2024)
11.12.5 Spectrum Pharmaceuticals Recent Development
11.13 Takeda
11.13.1 Takeda Company Detail
11.13.2 Takeda Business Overview
11.13.3 Takeda Immuno-Oncology Treatment Introduction
11.13.4 Takeda Revenue in Immuno-Oncology Treatment Business (2019-2024)
11.13.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Immuno-Oncology Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Immune Checkpoint Inhibitors
Table 3. Key Players of Monoclonal Antibodies
Table 4. Key Players of Cytokine-Based Immunotherapy
Table 5. Key Players of Cancer Vaccines
Table 6. Key Players of CAR-T Cell Therapy
Table 7. Global Immuno-Oncology Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Immuno-Oncology Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Immuno-Oncology Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Immuno-Oncology Treatment Market Share by Region (2019-2024)
Table 11. Global Immuno-Oncology Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Immuno-Oncology Treatment Market Share by Region (2025-2030)
Table 13. Immuno-Oncology Treatment Market Trends
Table 14. Immuno-Oncology Treatment Market Drivers
Table 15. Immuno-Oncology Treatment Market Challenges
Table 16. Immuno-Oncology Treatment Market Restraints
Table 17. Global Immuno-Oncology Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Immuno-Oncology Treatment Market Share by Players (2019-2024)
Table 19. Global Top Immuno-Oncology Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology Treatment as of 2023)
Table 20. Ranking of Global Top Immuno-Oncology Treatment Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Immuno-Oncology Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Immuno-Oncology Treatment Product Solution and Service
Table 24. Date of Enter into Immuno-Oncology Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Immuno-Oncology Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Immuno-Oncology Treatment Revenue Market Share by Type (2019-2024)
Table 28. Global Immuno-Oncology Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Immuno-Oncology Treatment Revenue Market Share by Type (2025-2030)
Table 30. Global Immuno-Oncology Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Immuno-Oncology Treatment Revenue Market Share by Application (2019-2024)
Table 32. Global Immuno-Oncology Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Immuno-Oncology Treatment Revenue Market Share by Application (2025-2030)
Table 34. North America Immuno-Oncology Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Immuno-Oncology Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Immuno-Oncology Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Immuno-Oncology Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Immuno-Oncology Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Immuno-Oncology Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Immuno-Oncology Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Immuno-Oncology Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Immuno-Oncology Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Immuno-Oncology Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Immuno-Oncology Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Immuno-Oncology Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Immuno-Oncology Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Immuno-Oncology Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Immuno-Oncology Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 49. Amgen Company Detail
Table 50. Amgen Business Overview
Table 51. Amgen Immuno-Oncology Treatment Product
Table 52. Amgen Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)
Table 53. Amgen Recent Development
Table 54. AstraZeneca Company Detail
Table 55. AstraZeneca Business Overview
Table 56. AstraZeneca Immuno-Oncology Treatment Product
Table 57. AstraZeneca Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)
Table 58. AstraZeneca Recent Development
Table 59. Bristol-Myers Squibb Company Detail
Table 60. Bristol-Myers Squibb Business Overview
Table 61. Bristol-Myers Squibb Immuno-Oncology Treatment Product
Table 62. Bristol-Myers Squibb Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)
Table 63. Bristol-Myers Squibb Recent Development
Table 64. Eli-Lilly Company Detail
Table 65. Eli-Lilly Business Overview
Table 66. Eli-Lilly Immuno-Oncology Treatment Product
Table 67. Eli-Lilly Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)
Table 68. Eli-Lilly Recent Development
Table 69. Roche Company Detail
Table 70. Roche Business Overview
Table 71. Roche Immuno-Oncology Treatment Product
Table 72. Roche Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)
Table 73. Roche Recent Development
Table 74. GlaxoSmithKline Company Detail
Table 75. GlaxoSmithKline Business Overview
Table 76. GlaxoSmithKline Immuno-Oncology Treatment Product
Table 77. GlaxoSmithKline Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)
Table 78. GlaxoSmithKline Recent Development
Table 79. Janssen Biotech Company Detail
Table 80. Janssen Biotech Business Overview
Table 81. Janssen Biotech Immuno-Oncology Treatment Product
Table 82. Janssen Biotech Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)
Table 83. Janssen Biotech Recent Development
Table 84. Merck Company Detail
Table 85. Merck Business Overview
Table 86. Merck Immuno-Oncology Treatment Product
Table 87. Merck Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)
Table 88. Merck Recent Development
Table 89. Novartis Company Detail
Table 90. Novartis Business Overview
Table 91. Novartis Immuno-Oncology Treatment Product
Table 92. Novartis Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Pfizer Company Detail
Table 95. Pfizer Business Overview
Table 96. Pfizer Immuno-Oncology Treatment Product
Table 97. Pfizer Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)
Table 98. Pfizer Recent Development
Table 99. Sanofi Company Detail
Table 100. Sanofi Business Overview
Table 101. Sanofi Immuno-Oncology Treatment Product
Table 102. Sanofi Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)
Table 103. Sanofi Recent Development
Table 104. Spectrum Pharmaceuticals Company Detail
Table 105. Spectrum Pharmaceuticals Business Overview
Table 106. Spectrum Pharmaceuticals Immuno-Oncology Treatment Product
Table 107. Spectrum Pharmaceuticals Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)
Table 108. Spectrum Pharmaceuticals Recent Development
Table 109. Takeda Company Detail
Table 110. Takeda Business Overview
Table 111. Takeda Immuno-Oncology Treatment Product
Table 112. Takeda Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)
Table 113. Takeda Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno-Oncology Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Immuno-Oncology Treatment Market Share by Type: 2023 VS 2030
Figure 3. Immune Checkpoint Inhibitors Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Cytokine-Based Immunotherapy Features
Figure 6. Cancer Vaccines Features
Figure 7. CAR-T Cell Therapy Features
Figure 8. Global Immuno-Oncology Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Immuno-Oncology Treatment Market Share by Application: 2023 VS 2030
Figure 10. Hospitals Case Studies
Figure 11. Ambulatory Surgical Center Case Studies
Figure 12. Others Case Studies
Figure 13. Immuno-Oncology Treatment Report Years Considered
Figure 14. Global Immuno-Oncology Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Immuno-Oncology Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Immuno-Oncology Treatment Market Share by Region: 2023 VS 2030
Figure 17. Global Immuno-Oncology Treatment Market Share by Players in 2023
Figure 18. Global Top Immuno-Oncology Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology Treatment as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Immuno-Oncology Treatment Revenue in 2023
Figure 20. North America Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Immuno-Oncology Treatment Market Share by Country (2019-2030)
Figure 22. United States Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Immuno-Oncology Treatment Market Share by Country (2019-2030)
Figure 26. Germany Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Immuno-Oncology Treatment Market Share by Region (2019-2030)
Figure 34. China Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Immuno-Oncology Treatment Market Share by Country (2019-2030)
Figure 42. Mexico Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Immuno-Oncology Treatment Market Share by Country (2019-2030)
Figure 46. Turkey Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Amgen Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)
Figure 49. AstraZeneca Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)
Figure 50. Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)
Figure 51. Eli-Lilly Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)
Figure 52. Roche Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)
Figure 54. Janssen Biotech Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)
Figure 55. Merck Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)
Figure 56. Novartis Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)
Figure 57. Pfizer Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)
Figure 58. Sanofi Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)
Figure 59. Spectrum Pharmaceuticals Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)
Figure 60. Takeda Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock